drugset / Trial / NCT01073826
Role of Interleukin-6 in Exercise
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of the study is to understand the role of interleukin-6 during physical activity in patients with type 2 diabetes.
Timeline
- Start
- 2010-02
- Primary completion
- 2015-11
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sitagliptin | Small molecule | 100 mg | Oral |
| Comparator | Tocilizumab | Monoclonal antibody | 8 mg/kg | Intravenous |